Skip to main content
. 2021 Oct 25;59(5):292–301. doi: 10.5114/reum.2021.110318

Table V.

Comparison of immunosenescence markers according to disease activity status of systemic lupus erythematosus patients

Variable Inactive SLE patients (n = 12) Active SLE patients (n = 41) p-value
CD4+CD57+ [%] 1.2 (0.7–2.4) 0.8 (0.6–1.9) 0.444
CD4+KLRG1+ [%] 2.1 (1.3–5.0) 2.5 (1.2–4.6) 0.772
CD8+CD57+ [%] 7.9 ±6.9 12.7 ±6.9 0.041*
CD8+KLRG1+ [%)] 8.4 ±5.3 15.2 ±7.4 0.004*
IFN-γ levels [pg/ml] 146.7 (130.2–210.8) 208.9 (148.3–233.8) 0.048*

IFN-γ – interferon γ, KLRG1 – killer cell lectin like receptor G1

*

p < 0.05 considered significant.